Previous 10 | Next 10 |
2024-05-13 13:53:13 ET More on AstraZeneca, Pfizer Pfizer's Bottom May Be Here - Its Rich Yield Is Tempting Pfizer: A 6% Yield And At 10-Year Lows Pfizer Stock: Not A Value Trap, Here's Why Pfizer to settle over 10,000 Zantac-related cancer claims: report ...
2024-05-13 13:24:17 ET More on Corbus Pharmaceuticals Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology Seeking Alpha’s Quant Rating on Corbus Pharmaceuticals Historical earnings data for Corbus Pharmaceuticals Financial i...
2024-05-13 12:07:12 ET Summary First Trust Morningstar Dividend Leaders Index Fund ETF holds 90 stocks of companies with higher yields and 5-year dividend growth. The FDL ETF is well diversified across sectors, but quite concentrated in financials and its top holdings. FDL is ...
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting PR Newswire 16 abstracts feature new data and post-hoc analyses of pivotal trials across several types of hard-to-treat cancers TOKYO , May 13, 2024 /PRNe...
2024-05-13 06:27:24 ET Pfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. However, recent developments suggest a potential turnaround for the pharmaceutical giant. On May 1, 2024, Pfizer reported better-than-exp...
2024-05-13 03:07:00 ET Pfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its dividend payout, meanwhile, has continued to rise again and again. This combination has pushed the dividend yield up to nearly 6%. Is this your chance to secure ...
2024-05-12 11:00:00 ET More on Acadia Pharma, BridgeBio Pharma, etc. ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation Rocket Pharmaceuticals: Cautiously Optimistic (Rating U...
2024-05-12 10:00:00 ET Summary PFE's fundamental performance has been decent despite the COVID-19 headwinds, with bullish support seemingly found at the $26s level. Despite a deteriorating balance sheet and upcoming patent cliff, the management continues to prioritize dividend saf...
2024-05-11 06:58:33 ET Summary Organon, Pfizer, and Bristol Myers all offer yields above 5% and can compete with most Treasuries, but only Organon is up YTD. Spinoffs often struggle in their initial years, but Organon's partial reversal of its decline since Merck's castoff h...
2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...
News, Short Squeeze, Breakout and More Instantly...
2024-07-24 10:13:00 ET If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are unsure about how strong its long-term prospects are, which ...
2024-07-24 10:08:31 ET DENVER, Colo., Jul 24, 2024 ( 247marketnews.com )- Sangamo Therapeutics, Inc. (Nasdaq: SGMO ) expounded on Pfizer’s (NYSE: PFE ) positive topline results from their Phase 3 AFFINE trial (NCT04370054) evaluating giroctocogene fitelparvovec, an invest...
2024-07-24 09:00:21 ET Pfizer Inc. (PFE) declaring a stock dividend of $0.42 per share on Ex-Date : July 25, 2024. Shareholders on record as of July 26, 2024 are eligible for the dividend. The payment date is scheduled for September 03, 2024, and the declaration was officially made ...